Home

Învăţare crucișător Joacate cu marker tumoral 481 Milestone Tradiţional Asociat

DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine

Tumor metastasis: Mechanistic insights and therapeutic interventions - Liu  - 2021 - MedComm - Wiley Online Library
Tumor metastasis: Mechanistic insights and therapeutic interventions - Liu - 2021 - MedComm - Wiley Online Library

p53 and Tumor Suppression: It Takes a Network: Trends in Cell Biology
p53 and Tumor Suppression: It Takes a Network: Trends in Cell Biology

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and  CA19-9 in Colorectal Cancer | HTML
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer | HTML

Diversity and Biology of Cancer-Associated Fibroblasts | Physiological  Reviews
Diversity and Biology of Cancer-Associated Fibroblasts | Physiological Reviews

Transcriptional characterization of conjunctival melanoma identifies the  cellular tumor microenvironment and prognostic gene signatures | Scientific  Reports
Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures | Scientific Reports

Frontiers | A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers  and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma
Frontiers | A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma

Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer  Progression | Scientific Reports
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports

Translationally Controlled Tumor Protein from Madurella mycetomatis, a  Marker for Tumorous Mycetoma Progression | The Journal of Immunology
Translationally Controlled Tumor Protein from Madurella mycetomatis, a Marker for Tumorous Mycetoma Progression | The Journal of Immunology

Transition to invasive breast cancer is associated with progressive changes  in the structure and composition of tumor stroma - ScienceDirect
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma - ScienceDirect

Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and  CA19-9 in Colorectal Cancer | HTML
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer | HTML

CAR T cell therapy and the tumor microenvironment: Current challenges and  opportunities: Molecular Therapy - Oncolytics
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities: Molecular Therapy - Oncolytics

Key biomarkers within the colorectal cancer related inflammatory  microenvironment | Scientific Reports
Key biomarkers within the colorectal cancer related inflammatory microenvironment | Scientific Reports

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

T-cell exhaustion in the tumor microenvironment | Cell Death & Disease
T-cell exhaustion in the tumor microenvironment | Cell Death & Disease

Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using  Immunohistochemistry | SpringerLink
Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry | SpringerLink

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA  19-9, CA 50 and CEA. - Abstract - Europe PMC
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. - Abstract - Europe PMC

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic  Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE

Loss of fragile site-associated tumor suppressor promotes antitumor  immunity via macrophage polarization | Nature Communications
Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization | Nature Communications

The cellular and molecular origin of tumor-associated macrophages | Science
The cellular and molecular origin of tumor-associated macrophages | Science

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

p32 promotes melanoma progression and metastasis by targeting EMT markers,  Akt/PKB pathway, and tumor microenvironment | Cell Death & Disease
p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment | Cell Death & Disease

Role of the tumor microenvironment in pancreatic cancer - Murakami - 2019 -  Annals of Gastroenterological Surgery - Wiley Online Library
Role of the tumor microenvironment in pancreatic cancer - Murakami - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

Frontiers | m6A RNA Methylation Regulators Contribute to Malignant  Progression and Have Clinical Prognostic Impact in Gastric Cancer
Frontiers | m6A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer